Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy. Bukhari S, Barakat AF, Eisele YS, Nieves R, et al. Circulation 2021;143:1335-1337.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bukhari S, Barakat AF, Eisele YS, Nieves R, et al. Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy. Circulation 2021;143:1335-1337.
PMID: 33779268